Top compounds associated with response to MYO19


Feature Type Standardized
Nominal ANOVA
mRNA BX-795 GDSC1000 pan-cancer AAC 0.076 0.03
mRNA necrosulfonamide CTRPv2 pan-cancer AAC 0.088 0.03
mRNA SCH-529074 CTRPv2 pan-cancer AAC 0.087 0.03
mRNA Bexarotene GDSC1000 pan-cancer AAC -0.078 0.03
mRNA AKT inhibitor VIII GDSC1000 pan-cancer AAC -0.075 0.03
mRNA TL-2-105 GDSC1000 pan-cancer AAC 0.07 0.03
mRNA Camptothecin GDSC1000 pan-cancer AAC 0.073 0.04
mRNA Ko-143 CTRPv2 pan-cancer AAC 0.082 0.04
mRNA Imatinib GDSC1000 pan-cancer AAC 0.12 0.04
mRNA HBX-41108 CTRPv2 pan-cancer AAC 0.093 0.04
Download CSV